Virtus Investment Advisers’s Gilead Sciences GILD Stock Holding History

Virtus Investment Advisers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.95M	Buy	23,368 +2,895	+14%	+$381K	0.69%	11
2026 Q1	$2.85M	Buy	20,473 +14,798	+261%	+$2.07M	0.79%	1
2025 Q4	$697K	Buy	5,675 +1,709	+43%	+$208K	0.19%	166
2025 Q3	$440K	Hold	3,966	–	–	0.13%	215
2025 Q2	$440K	Buy	3,966 +46	+1%	+$4.9K	0.15%	206
2025 Q1	$439K	Buy	+3,920	New	+$404K	0.12%	204
2023 Q3	–	Sell	-2,881	Closed	-$222K	–	261
2023 Q2	$222K	Sell	2,881 -2,895	-50%	-$231K	0.15%	178
2023 Q1	$479K	Hold	5,776	–	–	0.34%	95
2022 Q4	$496K	Hold	5,776	–	–	0.33%	89
2022 Q3	$356K	Buy	+5,776	New	+$364K	0.16%	126
2018 Q1	–	Sell	-5,558	Closed	-$398K	–	179
2017 Q4	$398K	Buy	5,558 +282	+5%	+$21.4K	0.04%	323
2017 Q3	$427K	Sell	5,276 -1,127	-18%	-$86.2K	0.04%	337
2017 Q2	$453K	Sell	6,403 -1,230	-16%	-$81.8K	0.04%	334
2017 Q1	$518K	Buy	+7,633	New	+$537K	0.05%	322
2016 Q4	–	Sell	-28,122	Closed	-$2.23M	–	496
2016 Q3	$2.23M	Buy	+28,122	New	+$2.28M	0.14%	208

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtus Investment Advisers's GILD Position: Q2 2026 in Review

Virtus Investment Advisers increased its Gilead Sciences (GILD) stake by 14% in Q2 2026, buying an estimated $381K and bringing the position to 23,368 shares worth $2.95M. The position accounts for 0.69% of the portfolio, ranked #11.

Virtus Investment Advisers first reported a position in GILD in Q3 2016 and has held it in 15 quarters since. 2,277 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Virtus Investment Advisers held 23,368 shares of Gilead Sciences worth $2.95M as of Q2 2026.
Virtus Investment Advisers bought 2,895 Gilead Sciences shares in Q2 2026, an estimated $381K.
Gilead Sciences made up 0.69% of Virtus Investment Advisers's portfolio in Q2 2026, its #11 holding.
Virtus Investment Advisers first reported a position in Gilead Sciences in Q3 2016 and has held it in 15 quarters since.
2,277 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.